- Home
- OPFI vs XBIT Comparison
OPFI vs XBIT Comparison
Compare OPFI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- XBIT
- Stock Information
- Founded
- OPFI 2009
- XBIT 2005
- Country
- OPFI United States
- XBIT United States
- Employees
- OPFI N/A
- XBIT N/A
- Industry
- OPFI Finance: Consumer Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- OPFI Finance
- XBIT Health Care
- Exchange
- OPFI Nasdaq
- XBIT Nasdaq
- Market Cap
- OPFI 174.4M
- XBIT 194.5M
- IPO Year
- OPFI N/A
- XBIT 2015
- Fundamental
- Price
- OPFI $11.44
- XBIT $3.95
- Analyst Decision
- OPFI Buy
- XBIT
- Analyst Count
- OPFI 2
- XBIT 0
- Target Price
- OPFI $7.50
- XBIT N/A
- AVG Volume (30 Days)
- OPFI 1.5M
- XBIT 98.0K
- Earning Date
- OPFI 03-06-2025
- XBIT 11-13-2024
- Dividend Yield
- OPFI N/A
- XBIT N/A
- EPS Growth
- OPFI 775.86
- XBIT N/A
- EPS
- OPFI 0.38
- XBIT N/A
- Revenue
- OPFI $260,661,000.00
- XBIT N/A
- Revenue This Year
- OPFI N/A
- XBIT N/A
- Revenue Next Year
- OPFI $6.51
- XBIT N/A
- P/E Ratio
- OPFI $31.50
- XBIT N/A
- Revenue Growth
- OPFI 23.85
- XBIT N/A
- 52 Week Low
- OPFI $2.35
- XBIT $3.51
- 52 Week High
- OPFI $11.96
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- OPFI 73.02
- XBIT 33.91
- Support Level
- OPFI $6.81
- XBIT $3.64
- Resistance Level
- OPFI $8.73
- XBIT $4.67
- Average True Range (ATR)
- OPFI 0.88
- XBIT 0.36
- MACD
- OPFI 0.40
- XBIT 0.02
- Stochastic Oscillator
- OPFI 89.12
- XBIT 30.10
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.